Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor protein p63 regulated 1 pseudogene (ENSG00000273721) is classified as a pseudogene related to the functional gene Tumor protein p63 regulated 1 (TPRG1). Pseudogenes are non-coding genetic elements that resemble protein-coding genes but typically do not produce functional proteins. There is no evidence that this pseudogene encodes a protein, plays a direct biological role, or serves as a therapeutic target. The protein-coding counterpart, TPRG1, is expressed in the cytoplasm and is linked to glandular cystitis, but the pseudogene itself is not associated with disease, has no therapeutic relevance, and is not targeted by known drugs[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor protein p63 regulated 1 pseudogene.